Ann: Biochip gFET technology design transfer to a commercial fab, page-26

agree FHC, NVIDIA is looking to invest its huge windfalls in a biotech company that has the very valuable biochem datasets needed to feed AI and let AI figure out how to chemically structure the next generation of drugs. BUT isn't it fascinating that NVIDIA is using its cloud hardware to do this AI, which is classical computing when actually quantum computing is the one that promises to speed up drug discovery (one of the many use cases).

This is where, I put more weight on tech like the 12CQ and the doors it can open to every day quantum computing power. ....and somewhat less emphasis on the biochip. For now, the biochip, if and when made in bulk is for a specific class of disease detection, as far as I can make out. Mo talks about world health, which if we look at largest jurisdictional populations where digital health is being tested, is China and India, with Indonesia the third. The primary need being met is not enough medical professionals to cover large populations or far flung remote regions. In Africa it's a chronic shortage of medical professionals full stop. A reliable diagnostic tool that is small, and allows digital connectivity allows some initial triage to be done, saving time and money. I recently discovered that our very own Sullivan Nicolaides is one of the largest pathology companies in the world and uses advanced digital information and AI, we could do worse than start with them IMO.